Stem cell enriched-epithelial spheroid cultures for rapidly assaying small intestinal radioprotectors and radiosensitizers in vitro
Year: 2018
Type: article
Abstract: Radiation therapy is one of the main treatment options for many cancer patients. Although high doses of radiation may maximize tumor cell killing, dose escalation is limited by toxicity to neighboring normal tissues. This limitation applies particularly to the small intestine, the second most radiosensitive organ in the body. Identifying small intestinal (SI) radioprotectors could enable dose escalation in the treatment of abdominopelvic malignancies. However, the only assay currently available to identify effects of radiomodulating drugs on the regenerating capacity of SI stem cells is the Withers-Elkind microcolony assay, which requires large numbers of mice, making it a costly and low throughput method. Here, we describe a novel spheroid formation assay (SFA) that utilizes SI stem cell-enriched three-dimensional epithelial spheroid cultures to identify gastrointestinal radiomodulators ex vivo. The SFA is scalable for high throughput screening and can be used to identify both radioprotectors and radiosensitizers.
Source: Scientific Reports
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: G1468253849, G1663282922, G1867270842, G1901027039, G2025267705, G2655961094, G2978072047, G3400514463, G378605414, Elucidating the Role of Fasting in GI Radioprotection: Applications in Pre-Clinical Pancreatic Cancer Model, Training Grant in Cancer Biology, G4458821658, Recruitment of First-Time, Tenure-Track Faculty Members, G6736661663, G788993117, Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation, Cancer Center Support Grant
OpenAlex ID: W2895938466
